JHM Biopharma’s recombinant human collagen is structurally identical to native collagen, featuring a full length triple-helical structure and elevated hydroxyproline content. It demonstrates high stability, non-im munogenicity, and complete biological activity.

Available in Type I, II, and III variants. It is a versatile raw material widely applied in regenerative medicine, tissue repair, and healthcare applications.

Molecular Composition

Full-length triple-helical structure (atelocollagen, telopeptide-free).

High hydroxyproline content, ensuring molecular stability.

Maintains structural integrity and full biological activity.

Industry-Leading Capacity

Annual production capacity of 100 kg high-purity (≥99.0%) Recombinant Human Collagen.

Medical-Grade Excellence

Manufactured under strict medical-grade quality systems.

Fully compliant with the highest clinical application standards.

Ensures safety, reliability, and consistency.

GMP-Compliant Manufacturing

Large-scale production base fully compliant with international GMP standards.

Supports industrial-scale supply and global commercialization.

Animal-Free Collagen

Genetically engineered, animal-free recombinant product.

Non-immunogenic and free from animal-derived pathogens.

Minimized viral risk, safer and more sustainable alternative.

Open for Collaboration

JHM Biopharma provides Recombinant Human Collagen raw materials and products. We welcome global partners to collaborate in building the future of synthetic biology and biopharmaceutical innovation.